Due to the late cancellation of the in-person Conference on Retroviruses and Opportunistic Infections (CROI), the 2020 Pre-CROI Community HIV Cure Research Workshop took place via Zoom conference on Saturday, March 7th.

We thank all presenters, panelists and participants – particularly Karine Dubé from the University of North Carolina, who generously provided and managed the Zoom technology that allowed the workshop to go ahead virtually.

Available slide presentations are posted below in PDF format (click on the titles), along with video links to the Zoom recordings. The PDF of the workshop program is also available for download.

The workshop was sponsored by:

AIDS Treatment Activists Coalition
AVAC
BEAT-HIV Community Advisory Board
DARE Community Advisory Board
defeatHIV Community Advisory Board
European AIDS Treatment Group 
I4C Community Advisory Board
NMAC
Treatment Action Group
University of Washington/Fred Hutch CFAR Cure Scientific Working Group 

Online Reports

An HIV cure may work differently for women and men – Roger Pebody, AIDSMap, March 30, 2020

HIV cure at CROI: new data on antibodies, vaccines and genetically engineered T-cells – Gus Cairns, AIDSMap, March 24, 2020

Agenda

Welcome and Introductions
Danielle Campbell, MPH
AIDS Treatment Activists Coalition; DARE

Michael Louella
defeatHIV

I4C Collaboratory Overview (video)
Dan H. Barouch, M.D., Ph.D.
Professor of Medicine, Harvard Medical School; Director, Center for Virology and Vaccine Research, BIDMC; Member, Ragon Institute of MGH, MIT, and Harvard

Update on HIV Gene Therapy Clinical Trials (video)
James L. Riley, Ph.D.
Associate Professor, Department of Microbiology, Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania

Women in HIV Cure Research Session

Sex Differences in HIV Cure Research & Status of Women’s Participation in Current Cure-Related Studies (video)
Liz Barr, Ph.D.
AIDS Clinical Trials Group, Baltimore, MD; University of Maryland, Baltimore County

The FRESH Cohort, South Africa (video)
Krista L. Dong, MD
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA; Infectious Disease Division, Massachusetts General Hospital

Women’s Involvement in HIV Cure-Related Research – Empirical Data, Unresolved Challenges and Opportunities for the Future (video)
Karine Dubé, DrPH
Assistant Professor, Public Health Leadership Program, UNC Gillings School of Global Public Health

Panel Discussion (video)
Liz Barr, Ph.D, Krista L. Dong, MD, Karine Dubé, DrPH, Danielle M. Campbell, MPH, Beth Peterson, MPH

ACTG A5370: Anti-PD-1 Antibody (Cemiplimab) in Participants with HIV-1 on Suppressive cART (video)
W. David Hardy, MD
Adjunct Professor of Medicine in the Division of Infectious Diseases at Johns Hopkins University School of Medicine

Cynthia Gay, MD, MPH
Associate Professor of Medicine, Division of Infectious Diseases; Medical Director, UNC HIV Cure Center

Analytical Treatment Interruptions (ATIs) Session

Introductory Summary of Ragon Meeting ATI Recommendations and Examples of Current ATI Trials Criteria (video)
Richard Jefferys
Treatment Action Group

Cases of HIV Transmission During ATIs: Published Reports and Community Response (video)
Lynda Dee
AIDS Action Baltimore

BEAT-HIV CAB Perspective, Solicitation of Discussion and Input for ATI Position Paper (video)
Bill Freshwater, Chris Roebuck, Ph.D, MPH, Beth Peterson, MPH
BEAT-HIV Collaboratory

Group Discussion: Community Advisory Board Participation (video)
CAB participation issues, communication, inter-CAB networking, plans for HIV2020 and AIDS2020 conferences